These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16817823

  • 1. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance.
    Topcu S, Tok D, Caliskan M, Ozcimen EE, Gullu H, Uckuyu A, Erdogan D, Zeyneloglu H, Muderrisoglu H.
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):75-80. PubMed ID: 16817823
    [Abstract] [Full Text] [Related]

  • 2. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S, Quadbeck B, Elsenbruch S, Gärtner R, Finke R, Mann K, Janssen OE.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1059-64. PubMed ID: 15136950
    [Abstract] [Full Text] [Related]

  • 3. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ, Goldenberg N, Sieve L, Wang P.
    Metabolism; 2008 Jul 07; 57(7):954-60. PubMed ID: 18555837
    [Abstract] [Full Text] [Related]

  • 4. Use of metformin in polycystic ovary syndrome.
    Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R.
    Am J Obstet Gynecol; 2008 Dec 07; 199(6):596-609. PubMed ID: 19084097
    [Abstract] [Full Text] [Related]

  • 5. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
    Meyer C, McGrath BP, Teede HJ.
    Diabetes Care; 2007 Mar 07; 30(3):471-8. PubMed ID: 17327307
    [Abstract] [Full Text] [Related]

  • 6. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
    Tan BK, Adya R, Chen J, Farhatullah S, Heutling D, Mitchell D, Lehnert H, Randeva HS.
    Cardiovasc Res; 2009 Aug 01; 83(3):566-74. PubMed ID: 19414528
    [Abstract] [Full Text] [Related]

  • 7. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E, Paterakis T, Alexandraki K, Piperi C, Aessopos A, Katsikis I, Katsilambros N, Kreatsas G, Panidis D.
    Hum Reprod; 2006 Jun 01; 21(6):1426-31. PubMed ID: 16497699
    [Abstract] [Full Text] [Related]

  • 8. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF, Nilas L, Madsbad S, Holst JJ.
    Metabolism; 2009 May 01; 58(5):586-93. PubMed ID: 19375579
    [Abstract] [Full Text] [Related]

  • 9. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ, Hutchison SK, Zoungas S.
    Trends Endocrinol Metab; 2007 Sep 01; 18(7):273-9. PubMed ID: 17698366
    [Abstract] [Full Text] [Related]

  • 10. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
    Diamanti-Kandarakis E, Economou FN, Livadas S, Tantalaki E, Piperi C, Papavassiliou AG, Panidis D.
    Kidney Blood Press Res; 2009 Sep 01; 32(1):24-31. PubMed ID: 19212122
    [Abstract] [Full Text] [Related]

  • 11. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Alexandraki K, Piperi C, Aessopos A, Paterakis T, Katsikis I, Panidis D.
    Metabolism; 2007 Jan 01; 56(1):129-34. PubMed ID: 17161235
    [Abstract] [Full Text] [Related]

  • 12. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, Paulson RJ.
    Fertil Steril; 2007 Apr 01; 87(4):870-5. PubMed ID: 17224152
    [Abstract] [Full Text] [Related]

  • 13. Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.
    Cho LW, Kilpatrick ES, Keevil BG, Coady AM, Atkin SL.
    Clin Endocrinol (Oxf); 2009 Feb 01; 70(2):233-7. PubMed ID: 18547343
    [Abstract] [Full Text] [Related]

  • 14. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.
    Diabetes; 2008 Jun 01; 57(6):1501-7. PubMed ID: 18375437
    [Abstract] [Full Text] [Related]

  • 15. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM.
    Gynecol Endocrinol; 2007 Mar 01; 23(3):146-52. PubMed ID: 17454168
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance and metformin in polycystic ovary syndrome.
    Ben-Haroush A, Yogev Y, Fisch B.
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug 10; 115(2):125-33. PubMed ID: 15262344
    [Abstract] [Full Text] [Related]

  • 17. Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.
    Genazzani AD, Strucchi C, Luisi M, Casarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR.
    Gynecol Endocrinol; 2006 Jan 10; 22(1):36-43. PubMed ID: 16522532
    [Abstract] [Full Text] [Related]

  • 18. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance.
    Nawrocka J, Starczewski A.
    Gynecol Endocrinol; 2007 Apr 10; 23(4):231-7. PubMed ID: 17505944
    [Abstract] [Full Text] [Related]

  • 19. Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?
    Topcu S, Caliskan M, Ozcimen EE, Tok D, Uckuyu A, Erdogan D, Gullu H, Yildirir A, Zeyneloglu H, Muderrisoglu H.
    Hum Reprod; 2006 Apr 10; 21(4):930-5. PubMed ID: 16373410
    [Abstract] [Full Text] [Related]

  • 20. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S, Falbo A, Russo T, Orio F, Tollino A, Zullo F.
    Minerva Ginecol; 2008 Feb 10; 60(1):77-82. PubMed ID: 18277354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.